Stock Events

Stock Events

Xilio Therapeutics (XLO) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.87

-0.58

-0.29

0

Details

Expected EPS

-0.11

Actual EPS

-0.62

Surprise EPS

-0.51

Surprise Percent

+463.64%

Description

Xilio Therapeutics (XLO) has reported earnings of -0.62 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.